ZIDCEF-125
Description
- Contains Ceftazidime 125 mg, a third-generation cephalosporin antibiotic
- Broad-spectrum activity against Gram-negative and some Gram-positive bacteria
- Effective in treating pediatric respiratory, urinary, skin, and ENT infections
- Bactericidal action through inhibition of bacterial cell wall synthesis
- Especially active against resistant strains, including Pseudomonas
- Pediatric formulation designed for accurate and safe dosing
- Should be used only under a physician’s guidance to prevent resistance
Composition
CEFTAZIDIME-125 MG,
Benefits
ZIDCEF-125 offers rapid and reliable relief from a wide range of bacterial infections in pediatric patients. Its powerful bactericidal action helps eliminate infections such as bronchitis, pneumonia, sinusitis, otitis media, and urinary tract infections. Being a third-generation cephalosporin, Ceftazidime is particularly useful in treating resistant or hospital-acquired infections. ZIDCEF-125 provides well-tolerated therapy with excellent safety in children when administered under medical supervision, ensuring quicker recovery and minimal recurrence of infection.
Introduction
ZIDCEF-125 is a pediatric antibiotic formulation containing Ceftazidime 125 mg, a third-generation cephalosporin known for its broad-spectrum antibacterial activity. It is especially effective against Gram-negative bacteria, including Pseudomonas aeruginosa. ZIDCEF-125 works by inhibiting bacterial cell wall synthesis, resulting in the destruction of bacteria. It is typically prescribed for respiratory tract infections, urinary tract infections, skin infections, and other bacterial conditions in children. Its pediatric-friendly formulation ensures accurate dosing and improved compliance among younger patients.
